当前位置:首页 - 行情中心 - 皓元医药(688131) - 财务分析

皓元医药

(688131)

  

流通市值:81.61亿  总市值:83.50亿
流通股本:2.06亿   总股本:2.11亿

皓元医药(688131)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.61亿元,每股收益0.30元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益297335.96万元,未分配利润88387.61万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产571352.89万元,负债274016.93万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入606,125,018.692,270,177,811.51,619,063,344.91,055,549,087.12
营业总成本500,107,881.661,900,882,004.661,383,328,088.18919,361,955.83
营业利润74,892,596.81236,817,376.92157,760,861.7278,476,846.78
利润总额73,258,571.58238,355,281.35157,832,706.4378,640,841.8
净利润61,178,293.66197,930,034.58140,779,655.4168,918,893.5
其他综合收益200,385.5422,673,517.3914,035,099.2912,837,511.63
综合收益总额61,378,679.2220,603,551.97154,814,754.781,756,405.13
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计3,363,203,135.353,174,918,772.72,376,880,587.72,227,859,454.34
非流动资产合计2,350,325,759.872,330,027,122.572,306,622,057.72,144,790,659.77
资产总计5,713,528,895.225,504,945,895.274,683,502,645.44,372,650,114.11
流动负债合计1,363,851,756.861,260,187,291.81,210,004,419.41,136,910,737.46
非流动负债合计1,376,317,512.221,340,503,672.54751,777,802.32592,842,163.17
负债合计2,740,169,269.082,600,690,964.341,961,782,221.721,729,752,900.63
归属于母公司股东权益合计2,948,187,946.512,877,877,144.942,704,179,683.132,621,241,196.55
股东权益合计2,973,359,626.142,904,254,930.932,721,720,423.682,642,897,213.48
负债和股东权益合计5,713,528,895.225,504,945,895.274,683,502,645.44,372,650,114.11
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计581,435,370.722,360,017,508.131,654,346,586.741,057,675,016.59
经营活动现金流出小计613,937,047.151,978,057,249.821,495,338,546.22980,575,236.32
经营活动产生的现金流量净额-32,501,676.43381,960,258.31159,008,040.5277,099,780.27
投资活动现金流入小计1,074,094,217.3329,357,419.5219,913,172.0416,778,889.08
投资活动现金流出小计1,011,057,176.63813,011,609.64199,118,409.29193,442,522.91
投资活动产生的现金流量净额63,037,040.7-783,654,190.12-179,205,237.25-176,663,633.83
筹资活动现金流入小计291,805,529.861,633,575,712.21605,040,019.79381,165,513.53
筹资活动现金流出小计136,872,625.76842,097,185.26568,561,561.84334,143,756.9
筹资活动产生的现金流量净额154,932,904.1791,478,526.9536,478,457.9547,021,756.63
汇率变动对现金及现金等价物的影响8,134,951.467,845,113.984,215,590.655,893,201.64
现金及现金等价物净增加额193,603,219.83397,629,709.1220,496,851.87-46,648,895.29
期末现金及现金等价物余额1,066,698,892.56873,095,672.73495,962,815.48428,817,068.32
最新报告期:2025-05-06
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
平安证券叶寅,倪亦道1.161.582.102025-05-06
国投证券马帅,冯俊曦1.151.341.612025-04-30
太平洋周豫,张崴1.181.471.862025-04-29
中信证券陈竹,王凯旋,韩世通1.181.471.812025-04-21
浙商证券孙建,王帅,胡隽扬1.181.451.892025-04-07
TOP↑